HIGHLIGHTS
- who: Kun-kai Su from the Qilu Hospital of Shandong University, China have published the research: Five-lipoxygenase-activating protein-mediated CYLD attenuation is a candidate driver in hepatic malignant lesion, in the Journal: (JOURNAL)
- what: The authors report that FLAP highly expresses in the resection tissues from HCC patients. This study reveals that both the 5LO/LTB4 bypass and the COX/PGE2 pathway in AAI-treated livers of canines do not change in expression, indicating that both pathways contribute less to the generation of lipid proinflammatory mediators . Based on the knowledge , the authors report . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.